Posterior Reversible Encephalopathy Syndrome - A Rare Complication of COVID-19 MIS-C

Abstract

As a direct consequence of the worldwide pandemic of the novel 2019 coronavirus disease (COVID-19, SARS-CoV-2 infection), pediatricians started to encounter a novel multisystem condition resulting from an aberrant immune response to SARS-CoV-2 in children and adolescents in early 2020. Due to partial clinical overlap with Kawasaki disease, it was originally assigned as Kawasaki-like disease, and later specified as a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS), or Multisystem inflammatory syndrome in children (MIS-C).

Keywords

• Posterior Reversible Encephalopathy Syndrome
• COVID-19 MIS-C